$ADPT News
Last published 1w ago
- 1w agoADPTAdaptive Biotechnologies Corp - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoADPTAdaptive Biotechnologies Reports Third Quarter 2026 Financial ResultsGlobeNewswireSEATTLE, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the
- 1w agoADPTAdaptive Biotechnologies Third Quarter Financial Results - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Adaptive Biotechnologies third quarter 2026 financial results conference call. At this time all participants are in a listen-only mode. After the speaker's presentat
- 3w agoADPTDo We Need To Reset The Rules Of Oncology? with Dr. Johnetta Blakely - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsIt feels like death by a thousand clicks. You've got to click the regimen. You're got to click to approve the medicine. You got to a click on your schedule. 22 years ago, truly, you walked into a room, you talked to the
- 3w agoADPT‘A little weasel…’: JD Vance humiliates El Sayed in Michigan; Abdul hits back, ‘a f**king wolverine’ - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsI feel bad for Abdul El-Sayed because I don't understand how this man could have so much hatred in his heart for the people and the places that gave him so much opportunity. Donald Trump and J.D. Vance can't seem to keep
- 4w agoADPTAdaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewswireSEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1mo agoADPTAdaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®GlobeNewswireUpdated guidelines establish a dedicated framework for routine MRD assessment across the multiple myeloma patient journey clonoSEQ named as an FDA-cleared assay for MRD assessment, with 10-6 sensitivity now preferred
- 1mo agoADPTAdaptive Biotechnologies (ADPT US) - 1774916 - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsOkay, it looks like we're running a couple of minutes behind, so we can quickly get started. Callum Tishmarsh here from the Life Science Tools and Diagnostics team at Morgan Stanley. Really pleased to be joined by the te
- 1mo agoADPTMorgan Stanley 24th Annual Global Healthcare Conference - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsOkay, it looks like we're running a couple of minutes behind, so we can quickly get started. Callum Tishmarsh here from the Life Science Tools and Diagnostics team at Morgan Stanley. Really pleased to be joined by the te
- 1mo agoADPTBILLIONS SPENT, AND STILL NO CURE. WHY HAS THE US’S WAR ON CANCER FALLEN SHORT? THIS IS AMERICA - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsThis is America and this is a country that declared war on cancer more than 50 years ago and still hasn't won it. Billions of dollars spent in the world's richest biomedical machine has produced groundbreaking science, g
- 2mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsMy name is Pei Wang. I'm the senior vice president at Eureka Therapeutics. Eureca is a clinical stage company developing innovative CAR-T called Artemis T-cell therapy in tackling solid tumors. I'm very happy to be joine
- 2mo agoADPTAdaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 3mo agoADPTAdaptive Biotechnologies Second Quarter Financial Results - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsThis video tutorial shows how to install Kali Linux 2017.1 LXDE on VMware Workstation or VMware Workspace. Kali LXD is a very simple and easy-to-use software that can be installed on your computer. To install it, click o
- 3mo agoADPTAdaptive Biotechnologies Reports Second Quarter 2026 Financial ResultsGlobeNewswireSEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the
- 4mo agoADPTAdaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes OfferingGlobeNewswireProceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibilityAdditional proceeds used to pay for the capped call with a premium of 100% and to repurchase $25 million of common
- 5mo agoADPTAt ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and ResearchGlobeNewswireSEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 5mo agoADPTAdaptive Biotechnologies to Participate in Upcoming Investor ConferencesGlobeNewswireSEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 6mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsAll right, we'll go ahead and get started. Thank you, everybody, for coming. Hopefully, everybody got a chance to get some food. I'm Najiba Mamadova from 10X Genomics, and before I hand things over to our speaker today,
- 6mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsI'm the Vice President of Research and Development at Alephis, and I'm happy to moderate this session, which is going to focus on the improved prediction of immunotherapy response. As we all know, immune checkpoint inhib
- 6mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsArutha Kulasengay, Tulia Brudeau, Chakra, Mike Suraci, and Carlo Bifulco would be participating in the panel, which will start at the bottom of the hour. And I'll start off with a quick presentation, and then Chakra is g
- 6mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsThe honor of introducing Dr. George Pendergrass, who is the CEO of the Lankan Institute for Medical Research, former editor-in-chief of Cancer Research, and Dr. Len Appelman, who's a professor at the University of Pittsb
- 6mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsGood afternoon, and thank you for joining us. My name is Jamie Butler, and on behalf of Hamamatsu, I want to welcome everyone to the session, and also on behalf our new partnership and friends at BioCare, welcome. Thank
- 6mo agoADPTEarnings Call - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsI'm very excited to be here at CITSE today with my colleague, Louise Dacruz, who's going and we're going to talk to you really about a couple different things. There's going to be some technology discussion, product disc
- 6mo agoADPTAdaptive Biotechnologies First Quarter Financial ResultsADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Adaptive Biotechnologies First Quarter Financial Results. At this time, all participants are in listen only mode. After the speaker's presentation, there will be a q
- 6mo agoADPTAdaptive Biotechnologies Reports First Quarter 2026 Financial ResultsGlobeNewswireSEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive
- 7mo agoADPTAdaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026GlobeNewswireSEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 9mo agoADPTAdaptive Biotechnologies Fourth Quarter Financial Results - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Adaptive Biotechnologies fourth quarter and full year earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's present
- 9mo agoADPTAdaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireSEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive
- 9mo agoADPTAdaptive Biotechnologies to Participate in Upcoming Investor ConferencesGlobeNewswireSEATTLE, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 9mo agoADPTASH NEWS TV 2025: WELCOME TO #ASH25 - ADAPTIVE BIOTECHNOLOGIES CORPEarnings Call TranscriptsWelcome to Orlando, Florida, home of the 67th ASH Annual Meeting and Exposition, where hundreds of sessions, thousands of abstracts, and countless ways to experience the best in hematology will take place over the next f
- 9mo agoADPTAdaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026GlobeNewswireSEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 10mo agoADPTAdaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 ResultsGlobeNewswireSEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 10mo agoADPTAdaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireSEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 11mo agoADPTPFEAdaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with PfizerGlobeNewswireA target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive's proprietary TCR-antigen datasets for research and development in
- 11mo agoADPTAdaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual DiseaseGlobeNewswireSEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 11mo agoADPTAdaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual MeetingGlobeNewswireSEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 11mo agoADPTAdaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual MeetingGlobeNewswireSEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies to Participate in Upcoming Investor ConferencesGlobeNewswireSEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies Reports Third Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive
- 1y agoADPTAdaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025GlobeNewswireSEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoADPTAdaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoADPTAdaptive Biotechnologies Reports Second Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive
- 1y agoADPTAdaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025GlobeNewswireSEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®GlobeNewswireSEATTLE, July 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTGRNDTRUPVCSA+1Grindr Appoints Veteran Public Company CFO and Audit Committee Chair Chad Cohen to Board of DirectorsBusiness WireCohen to serve as Chair of the Audit Committee Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc.
- 1y agoADPTAdaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid CancersGlobeNewswireSEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
- 1y agoADPTAdaptive Biotechnologies Reports First Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive